Lymphomatoid granulomatosis natural history

Jump to navigation Jump to search

Lymphomatoid granulomatosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphomatoid granulomatosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphomatoid granulomatosis natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphomatoid granulomatosis natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphomatoid granulomatosis natural history

CDC on Lymphomatoid granulomatosis natural history

Lymphomatoid granulomatosis natural history in the news

Blogs on Lymphomatoid granulomatosis natural history

Directions to Hospitals Treating Lymphomatoid granulomatosis

Risk calculators and risk factors for Lymphomatoid granulomatosis natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kamal Akbar, M.D.[2]

Overview

Prognosis is generally variable and the 5-year mortality rate of patients with Lymphmatoid granulomatosis is approximately 63-90%. In many instances there is totally remission of the disease

Natural History, Complications, and Prognosis

Natural History

  • The symptoms of Lymphomatoid granulomatosis usually develop in the fifth to the sixth decade of life, and start with symptoms such as Cough, Dyspnea , and Chest tightness. Patient mostly present with pulmonary symptoms but in 40-50% of cases patients will present with cutaneous symptoms and then 30 present of patients will present with CNS symptoms.[1]

Complications

  • The most common complication of the disease can be Lymphoma. In some cases the disease does progress to lymphoma if patient is not cared for.[2][3]

Prognosis

  • Depending on the extent of the disease at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor.[4]

References

  1. Messana, Kate; Marburger, Trent; Bergfeld, Wilma (2015). "EBV-Negative Cutaneous Lymphomatoid Granulomatosis With Concomitant EBV-Positive Pulmonary Involvement". The American Journal of Dermatopathology. 37 (9): 707–711. doi:10.1097/DAD.0000000000000198. ISSN 0193-1091.
  2. Grimm, Kate E.; O'Malley, Dennis P. (2019). "Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues". Annals of Diagnostic Pathology. 38: 6–10. doi:10.1016/j.anndiagpath.2018.09.014. ISSN 1092-9134.
  3. Song JY, Pittaluga S, Dunleavy K, Grant N, White T, Jiang L; et al. (2015). "Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations". Am J Surg Pathol. 39 (2): 141–56. doi:10.1097/PAS.0000000000000328. PMC 4293220. PMID 25321327.
  4. Halvani A, Owlia MB, Sami R (2010). "Lymphomatoid granulomatosis with splenomegaly and pancytopenia". Zhongguo Fei Ai Za Zhi. 13 (1): 84–6. doi:10.3779/j.issn.1009-3419.2010.01.17. PMC 6000673. PMID 20672711.

Template:WH Template:WS